- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Patent holdings for IPC class A61P 19/08
Total number of patents in this class: 1979
10-year publication summary
|
90
|
63
|
110
|
134
|
138
|
134
|
150
|
166
|
134
|
58
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1855 |
26 |
| Alexion Pharmaceuticals, Inc. | 636 |
24 |
| Société des Produits Nestlé S.A. | 9220 |
23 |
| The Regents of the University of California | 19839 |
22 |
| Novartis AG | 10883 |
20 |
| Ascendis Pharma Growth Disorders A/S | 55 |
19 |
| Takeda Pharmaceutical Company Limited | 2708 |
18 |
| Genzyme Corporation | 1238 |
16 |
| BioMarin Pharmaceutical Inc. | 378 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3365 |
13 |
| Acceleron Pharma Inc. | 358 |
11 |
| Megmilk Snow Brand Co., Ltd. | 200 |
11 |
| Osaka University | 3367 |
11 |
| Centre National de La Recherche Scientifique | 10350 |
10 |
| Amgen Inc. | 4055 |
10 |
| Wisconsin Alumni Research Foundation | 3864 |
10 |
| Nestec S.A. | 2678 |
9 |
| AstraZeneca AB | 2933 |
9 |
| Carna Biosciences, Inc. | 61 |
9 |
| Chugai Seiyaku Kabushiki Kaisha | 1338 |
9 |
| Other owners | 1684 |